Study of SYH2053 for high cholesterol in Chinese adults
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests a new medication called SYH2053 for people with high cholesterol or mixed high cholesterol and triglycerides. If you have high LDL cholesterol and are not taking strong cholesterol medicines, you may be able to join. The study will see if this drug is safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your fasting LDL cholesterol is above the recommended level based on your risk category (low risk: 130-188 mg/dL; moderate risk: 100-188 mg/dL).
- Your fasting triglycerides are below 500 mg/dL.
- You do not have a known genetic form of high cholesterol (familial hypercholesterolemia).
- You have not taken most cholesterol-lowering drugs (like statins, fibrates, ezetimibe) in the 90 days before the study, or certain newer injectable medicines in the last 6 months to 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called SYH2053 to see if it helps lower 'bad' cholesterol more effectively when added to your current statin therapy. It is for patients whose cholesterol is still not at their doctor's target level, and it aims to improve heart health.
This study tests a new injection called SYH2053 for people with HeFH, a genetic condition that causes very high cholesterol. It looks at whether the injection can safely lower LDL cholesterol when added to standard statin therapy.
This study tests a new injectable medication called HST101 for lowering cholesterol in people who are already taking cholesterol pills but still have high levels. It may help if you have heart disease or are at high risk.
This trial tests an investigational injection called SYH2062 in healthy adults to see if it's safe. It helps researchers understand how the drug affects the body before testing in patients.
This trial tests an investigational injection called SYH2070 to lower cholesterol and triglycerides in people who are already on a stable statin therapy. It may be a new option for those with mixed hyperlipidemia who need additional lipid control.
This study tests a new injection called SYH2070 for people with high triglycerides and high LDL cholesterol. The goal is to see if a single dose is safe and how the body processes the medication. It is for people who have not been on cholesterol-lowering drugs recently.
Hear when a new Non-familial Hypercholesterolemia and Mixed Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.